Consumer Products Safe Testing Act

Consumer Products Safe Testing Act - Declares the policy that Federal departments and agencies shall encourage the development and use of product testing procedures that accurately reflect the acute health effects on humans of certain products, including consumer products and products containing hazardous or toxic substances, but which do not rely upon animals. Directs each Federal department or agency head (head), within one year, to: (1) review and evaluate any regulation, guideline, or recommendation issued by such department or agency which requires, recommends, or encourages the use of the Draize or other animal acute toxicity test for the purpose of evaluation of the safety of a regulated product; (2) review and evaluate nonanimal alternatives with the potential for partial or full replacement of the products regulated; and (3) promulgate regulations, guidelines, or recommendations that specify that a nonanimal acute toxicity test or battery of tests (NATT) should be used instead of an animal acute toxicity test unless that head determines that the NATT is less likely to predict the acute health effects on humans of a product than the animal acute toxicity test. Requires the appropriate head, if a determination is made that no NATT is as likely to predict the human reaction to the regulated product as the Draize or other animal acute toxicity test, to publish in the Federal Register an explanation of all options considered and the justification for continuing the animal acute toxicity test, which shall be subject to public comment. Provides for periodic review of animal acute toxicity testing regulations. Makes this Act inapplicable to regulations, guidelines, or recommendations related to medical research.